Clinical Trial Update: Non-interventional Study on Time to Response and Quality of Life in Relapsed/Refractory Multiple Myeloma When Treated With Lenalidomide in Second Line

View source ↗

Summary

This is a completed non-interventional study assessing time to response and quality of life in relapsed/refractory multiple myeloma patients treated with lenali…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Revlimid (lenalidomide)

Snippet

Sponsor: Hareth Nahi | Conditions: Multiple Myeloma | Status: COMPLETED